Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SAI Life Sciences (SAILS12 IN)
Watchlist
9
Analysis
Health Care
•
India
SAI Life Sciences Limited develops pharmaceuticals. The Company focuses on drug and active ingredient discovery, development, and manufacturing. SAI Life Sciences manages research facilities worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SAI Life Sciences
•
17 Dec 2024 10:45
Sai Life Sciences IPO Trading - Strong Anchor Demand with Decent Overall Coverage
Sai Life Sciences raised around US$360m in its India IPO. In this note, we will talk about the demand and trading dynamics.
Akshat Shah
Follow
227 Views
Share
bullish
•
SAI Life Sciences
•
12 Dec 2024 15:25
Sai Life Sciences IPO - Quick Thoughts on Peer Comp and Valuation
Sai Life Sciences is looking to raise up to US$360m in its upcoming India IPO. In this note, we will undertake a quick peer comparison and talk...
Akshat Shah
Follow
285 Views
Share
bullish
•
SAI Life Sciences
•
11 Dec 2024 11:05
Sai Life Sciences Pre-IPO - Portfolio Expansion and Increased Production Capacity to Drive Growth
Sai Life Sciences is looking to raise up to US$360m in its upcoming India IPO. In this note, we talk about the company’s historical performance.
Akshat Shah
Follow
252 Views
Share
bullish
•
SAI Life Sciences
•
10 Dec 2024 17:37
SAI Life Sciences IPO- Growing and Profitable Business; Aggressive Pricing Limits Upside Potential
SAI Life Sciences intends to raise INR9.5B via India IPO. The IPO proceeds will be used for debt repayment. Marquee clientele and diverse portfolio...
Tina Banerjee
Follow
276 Views
Share
bullish
•
SAI Life Sciences
•
23 Jul 2024 10:15
Sai Life Sciences Pre-IPO Tearsheet
SAI Life Sciences(SLS) is looking to raise up to US$500m in its upcoming India IPO. The deal will be run by Kotak, IIFL, Jefferies and MS.
Sumeet Singh
Follow
297 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x